Skip to main content
Egyptian Rheumatology and Rehabilitation

Table 3 Descriptive and clinical data of the studied cases after 3 months of anti-TNF treatment and its comparison to clinical data before receiving biologic treatment

From: Role of serum survivin as a predictor of response to biological treatment in rheumatoid arthritis patients

Variable

Mean ± SD

Range

Sign. to pre-treatment data

HAQ score

1.1 ± 0.42

0.8–2.3

P < 0.0001

Number of tender joints

3 ± 1.8

0–7

P < 0.0001

Number of swollen joints

2.8 ± 1.3

1–5

P < 0.0001

ESR

19.3 ± 12.1

5–40

P < 0.0001

CRP

5.5 ± 3.5

3.6–23.1

P = 0.0013

DAS 28

3.7 ± 0.84

0.6–18

P < 0.0001

  1. ESR Erythrocyte sedimentation rate, CRP C-reactive protein, DAS Disease activity score, HAQ Health assessment questionnaire
  2. Significant at P ≤ 0.05
Back to article page